Abbonarsi

Nitric oxide production during exercise in chronic heart failure - 10/09/11

Doi : 10.1016/S0002-8703(97)70124-8 
Hitoshi Adachi, MD, Paul H. Nguyen, PhD, Romualdo Belardinelli, MD, Dodie Hunter, MD, Tyler Jung, MD, Karlman Wasserman, MD, PhD
Torrance, Calif. 

Abstract

In chronic heart failure (CHF), the ventilatory response is increased compared with normal. This response is, in part, caused by reduced perfusion to ventilated lung. Nitric oxide (NO) is a potent vasodilator and may have an important role in pulmonary vasodilatation during exercise. NO is present in exhaled air. The amount of NO in exhaled air, when breathing NO-free compressed air, is known to increase in normal subjects during exercise. In this study, we quantified NO output in exhaled air in patients with CHF during exercise. Six patients with CHF (New York Heart Association Class II and III; two with dilated cardiomyopathy, three with ischemic heart disease, and one with hypertensive heart disease) and six normal subjects were studied with a symptom-limited incremental exercise test on a cycle ergometer. Oxygen uptake (v̇O2 ), carbon dioxide output (v̇CO2 ), and minute ventilation (v̇E) were measured breath by breath with a mass spectrometer, flow meter, and computer. The NO concentration was continuously measured in mixed expired air by chemiluminescence. Peak exercise work rate was lower in patients with CHF than in normal subjects (71.3 ± 41.6 W vs 257.0 ± 49.7 W; p < 0.01). Patients with CHF showed a higher v̇E/v̇CO2 level at peak exercise than normal subjects (CHF, 47.0 ± 10.7; normal subjects, 35.6 ± 5.2; p < 0.01). NO concentration of exhaled air at rest was lower in CHF patients than in normal subjects (4.0 ± 2.2 ppb vs 10.5 ± 6.2 ppb, respectively; p < 0.05). NO output from the respiratory tract (v̇NO) was significantly lower in patients with CHF compared with normal subjects at rest (45.3 ± 24.3 nl/min, 117.5 ± 60.1 nl/min, respectively, p < 0.05), and although it increased during exercise, it did not increase in patients with CHF as much as in normal subjects (75.3 ± 43.4 nl/min vs 512.9 ± 253.6 nl/min, respectively; p < 0.01). The increase above rest (exercise/rest) was smaller in patients with CHF than in normal subjects (2.10 ± 1.92 vs 4.81 ± 2.67, p < 0.05). These data support the concept that the smaller increase in NO production (v̇NO) during exercise may be responsible for a blunted vasodilation in patients with CHF, resulting in a smaller reduction in dead space/tidal volume and v̇E/v̇CO2 at the lactic acidosis threshold than normal. This finding may play a role in the abnormally high ventilatory response to exercise in patients with CHF.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 From the Division of Respiratory and Critical Care Physiology and Medicine Division of Cardiology, Harbor-UCLA Medical Center.
 Reprint requests: Hitoshi Adachi, MD, Gunma Prefectural Cardiovascular Center, 3-12, Kameizumi, Maebashi, Gunma 371, Japan.
 0002-8703/97/$5.00 + 0 4/1/82563


© 1997  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 134 - N° 2

P. 196-202 - agosto 1997 Ritorno al numero
Articolo precedente Articolo precedente
  • Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function
  • Edward F. Philbin, Thomas A. Rocco
| Articolo seguente Articolo seguente
  • Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: Preliminary experience with a portable device
  • Pompilio Faggiano, Antonio D’Aloia, Anna Gualeni, Aldo Lavatelli, Amerigo Giordano

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.